IL6 and diabetic cardiomyopathy: Mechanistically, inulin suppresses pro-inflammatory cytokines (e.g., IL-6, TNF-α), thereby attenuating systemic inflammation, preserving mitochondrial function, and inhibiting diabetic cardiomyopathy progression (39).